GGrantIndex
Sort

11,323 grants matching glioblastoma

Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma

$40,014
Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Three-dimensional characterization of epigenomic intratumoral heterogeneity in IDH-mutant glioma

$39,995
Radhika Mathur · University Of California, San Francisco · F32 · FY2021 · CA

Integrative Deep Learning Models for Multimodal Markers of Cancer Treatment Outcomes

$39,869
Olivia Krebs · Case Western Reserve University · F99 · FY2024 · CA

Iron Oxide Nanoparticle-Mediated Radiation Delivery for Glioblastoma Treatment

$39,851
Richard Aaron Revia · University Of Washington · F31 · FY2018 · CA

Signaling Regulation of GABP-Mediated Mutant TERT Promoter Activation in Glioma

$39,812
Andrew McKinney · University Of California, San Francisco · F31 · FY2019 · CA

Engineering Brain Cancer in a Dish: Hydrogel-based 3D in vitro Models for Pediatric Brain Tumor

$39,783
Sauradeep Sinha · Stanford University · F31 · FY2022 · CA

A 3D Model of the Perivascular Niche to Investigate Glioblastoma Invasion

$39,703
Kayla Wolf · University Of California Berkeley · F31 · FY2018 · CA

Ceramide and Cell Metabolism: Defining the Role of Sphingolipids in Modulating Mitochondrial Bioenergetics of Chronic Lymphocytic Leukemia

$39,698
Luke Remington Vass · University Of Virginia · F99 · FY2024 · CA

Investigating PTEN:Ki-67 interaction and its role in DNA damage repair

$39,681
Brandon Marshall Jones · University Of California, San Diego · F31 · FY2022 · CA

p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation

$39,583
Monica Venere · Cleveland Clinic Lerner Com-Cwru · F32 · FY2009 · NS

Defining the Function of APOE in Autophagy and Neurodegeneration

$39,581
Gianna Fote · University Of California-Irvine · F30 · FY2019 · AG

Molecular mediators of tumor suppression for the PTPRD phosphatase in gliomas

$39,576
Berenice Ortiz · Sloan-Kettering Inst Can Research · F31 · FY2013 · CA

Engineering RNA-nanoparticles to enhance dendritic cell mediated treatment of glioblastoma

$39,557
Adam Grippin · University Of Florida · F30 · FY2018 · CA

High-throughput screen for specific small-molecule inhibitors of HIF-2A activity

$39,500
Mei Yee Koh · University Of Tx Md Anderson Can Ctr · R03 · FY2012 · DA

Stem Cells And Neurogenesis

$39,285
Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG

Targeting brain tumor initiating cell-specific super-enhancer associated genes to treat glioblastoma

$39,247
Derrick Lee · University Of California, San Diego · F31 · FY2020 · CA

Novel Bioprinted Neural Stem Cell-Embedded Hydrogel Matrices for Enhanced Treatment of Glioblastoma

$39,212
Lauren Kass · Univ Of North Carolina Chapel Hill · F31 · FY2023 · NS

Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells

$39,128
Jian Hu · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA

Investigating virus- and vaccine-specific T cells in glioblastoma

$39,117
Pamela Rosato · Dartmouth College · R01 · FY2023 · CA

Assessing the Robustness of Radiogenomic Associations using Deep Neural Networks in Glioblastoma Multiforme

$39,107
Nova Fu-Juan Smedley · University Of California Los Angeles · F31 · FY2019 · CA

Investigating PTEN:Ki-67 interaction and its role in DNA damage repair

$38,965
Brandon Marshall Jones · University Of California, San Diego · F31 · FY2021 · CA

Integrative Deep Learning Models for Multimodal Markers of Cancer Treatment Outcomes

$38,933
Olivia Krebs · Case Western Reserve University · F99 · FY2025 · CA

Wnt/Planar Cell Polarity Contribution to Glioblastoma Multiforme Invasion and Therapeutic Resistance

$38,911
Courtney Anne Dreyer · University Of California At Davis · F31 · FY2022 · CA

The Role of IL-1 in Glioblastoma-Associated Angiogenesis and Tumor Progression

$38,812
Cameron Herting · Emory University · F31 · FY2019 · NS

Neural stem cells proteomic contribution to glioblastoma malignancy

$38,773
Emily Shannon Norton-Ramos · Mayo Clinic Jacksonville · F31 · FY2022 · NS